Next-generation treatments for mental disorders.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23052292.
- Also identified by DOI 10.1126/scitranslmed.3004873.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There has been a steady retreat by the private sector away from developing medications for mental disorders. This retreat comes just as research is identifying new molecular targets, new clinical targets, and new uses of current treatments that may serve as the basis for the next generation of treatments for mental disorders.
Medical subject headings
- Antidepressive Agents
- Antidepressive Agents/therapeutic use
- Drug Discovery
- Humans
- Mental Disorders
- Mental Disorders/drug therapy
- Mental Disorders/genetics
- Mental Disorders/metabolism
- Neuronal Plasticity
- Neuronal Plasticity/drug effects
- Psychiatry
- Psychiatry/methods